» Articles » PMID: 26513295

Evaluation of Pentacyclic Triterpenes Found in Perilla Frutescens for Inhibition of Skin Tumor Promotion by 12-O-tetradecanoylphorbol-13-acetate

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Oct 30
PMID 26513295
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

A series of pentacyclic tritperpenes found in Perilla frutescens (P. frutescens), including ursolic acid (UA), oleanolic acid (OA), corosolic acid (CA), 3-epi-corosolic acid (3-epiCA), maslinic acid (MA), and 3-epi-maslinic acid (3-epiMA) were evaluated for their effects on epidermal cell signaling, proliferation, and skin inflammation in relation to their ability to inhibit skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate (TPA) and compared to UA as the prototype compound. All compounds were given topically 30 min prior to each TPA application and significantly inhibited skin tumor promotion. 3-epiCA and MA were significantly more effective than UA at inhibiting tumor development. All of these compounds significantly inhibited epidermal proliferation induced by TPA, however, CA, 3-epiCA and MA were more effective than UA. All compounds also reduced skin inflammation (assessed by infiltration of mast cells and T-cells) and inflammatory gene expression induced by TPA, however, 3-epiCA and MA were again more effective than UA. The greater ability of 3-epiCA and MA to inhibit skin tumor promotion was associated with greater reduction of Cox-2 and Twist1 proteins and inhibition of activation (i.e., phosphorylation) of IGF-1R, STAT3 and Src. Further study of these compounds, especially 3-epiCA and MA, for chemopreventive activity in other cancer model systems is warranted.

Citing Articles

The Role and Mechanism of in Cancer Treatment.

Huang S, Nan Y, Chen G, Ning N, Du Y, Lu D Molecules. 2023; 28(15).

PMID: 37570851 PMC: 10421205. DOI: 10.3390/molecules28155883.


Deep Learning Approach for Predicting the Therapeutic Usages of Unani Formulas towards Finding Essential Compounds.

Wijaya S, Nasution A, Batubara I, Gao P, Huang M, Ono N Life (Basel). 2023; 13(2).

PMID: 36836796 PMC: 9959740. DOI: 10.3390/life13020439.


Immunomodulatory effects and structure-activity relationship of botanical pentacyclic triterpenes: A review.

Harun N, Septama A, Ahmad W, Suppian R Chin Herb Med. 2022; 12(2):118-124.

PMID: 36119799 PMC: 9476727. DOI: 10.1016/j.chmed.2019.11.007.


Extracts of var. (Odash.) Kudo Leaves Have Antitumor Effects on Breast Cancer Cells by Suppressing YAP Activity.

Kim C, Shin Y, Choi S, Oh S, Kim K, Jeong H Evid Based Complement Alternat Med. 2021; 2021:5619761.

PMID: 33628300 PMC: 7899781. DOI: 10.1155/2021/5619761.


Role of AMPK and PPARα in the anti-skin cancer effects of ursolic acid.

Junco J, Cho J, Mancha A, Malik G, Wei S, Kim D Mol Carcinog. 2018; 57(12):1698-1706.

PMID: 30129681 PMC: 6519015. DOI: 10.1002/mc.22890.


References
1.
Kim M, Kim H . Perilla leaf extract ameliorates obesity and dyslipidemia induced by high-fat diet. Phytother Res. 2009; 23(12):1685-90. DOI: 10.1002/ptr.2811. View

2.
Kowalczyk M, Junco J, Kowalczyk P, Tolstykh O, Hanausek M, Slaga T . Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice. Int J Oncol. 2013; 43(3):911-8. PMC: 3787890. DOI: 10.3892/ijo.2013.2005. View

3.
Riggs P, Angel J, Abel E, DiGiovanni J . Differential gene expression in epidermis of mice sensitive and resistant to phorbol ester skin tumor promotion. Mol Carcinog. 2005; 44(2):122-36. DOI: 10.1002/mc.20127. View

4.
Urushima H, Nishimura J, Mizushima T, Hayashi N, Maeda K, Ito T . Perilla frutescens extract ameliorates DSS-induced colitis by suppressing proinflammatory cytokines and inducing anti-inflammatory cytokines. Am J Physiol Gastrointest Liver Physiol. 2014; 308(1):G32-41. DOI: 10.1152/ajpgi.00294.2014. View

5.
Shanmugam M, Dai X, Kumar A, Tan B, Sethi G, Bishayee A . Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies. Biochem Pharmacol. 2013; 85(11):1579-87. DOI: 10.1016/j.bcp.2013.03.006. View